Equifax Inc Dossier
|
SectorIndustrials IndustryResearch and Consulting Services Beta (adjusted)1.19 Intrinsic Value $219.49median of 6 methods · middle span $213-$266based on filings through 30 Jun 2026 Market Price $139.73Price as of 1 Oct 2026 Significantly undervaluedIntrinsic value is 57% above the market price −50% · IV below pricenear fair value ±15%IV above price · +50% marker beyond scale (+57%) Data confidence Sign in to view data confidence Market Cap $16.4B Enterprise Value $21.7B Shares Outstanding 118.9M diluted Moat Rating Narrow Next Earnings Date20 Oct 2026 Last ex-dividend22 May 2026 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary Equifax entered the second half of 2026 with strong operating momentum: second-quarter revenue increased 11%, organic local-currency growth was 9%, adjusted EPS increased 13%, and the New Product Vitality Index reached 16%, above the company's 10% long-term goal. Management's FY 2026 guidance calls for 10.5%-11.6% reported revenue growth and adjusted EPS of $8.39-$8.69. Additional upside could come from $150 million of targeted AI-driven cost reductions through 2028, government contracts signed in the first half with approximately $300 million of annual contract value that should principally benefit 2027 and later, and the planned Círculo de Crédito acquisition. The principal counterweights are mortgage-market cyclicality, execution and integration risk, cybersecurity and data-regulation exposure, and recent legal charges. The latest issuer-hosted quote available before the as-of date was $193.79 on August 28, 2026. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Street view · analyst 12-month targets Low · most bearish analyst$179.00 Mean target$210.52 High · most bullish analyst$245.00 Our research · scenarios, merits, risks, and invalidation triggersResearch as of 2 Sep 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario $179.0020% Revenue falls below guidance as mortgage demand weakens or diversified-market growth slows, new-product vitality falls below the long-term goal, legal or regulatory costs persist, or the Círculo de Crédito transaction is delayed or proves more difficult to integrate than expected. Base CaseCentral scenario $210.5255% Matches the consensus meanEquifax delivers within its FY 2026 revenue and adjusted-EPS guidance ranges, new-product vitality remains above the 10% goal, mortgage growth moderates from the strong second quarter, and the Mexico transaction closes without a material disruption. Bull CaseUpside scenario $245.0025% Revenue and adjusted EPS finish near or above the upper ends of 2026 guidance, mortgage activity remains supportive, the 16% Vitality Index translates into durable diversified-market growth, AI initiatives deliver substantial productivity gains, and Círculo de Crédito closes on schedule with a credible integration path. Scenarios are anchored to street consensus at the research date, with our probabilities and rationale. Key Investment Merits
Key Investment Risks
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |